Methocarbamol Pregnancy and Breastfeeding Warnings

Brand names: Atmeksi, Carbacot, Robaxin, Robaxin-750, Skelex, Tanlor

Medically reviewed by Drugs.com. Last updated on Jul 25, 2025.

Methocarbamol Pregnancy Warnings

This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.

US FDA pregnancy category: Not assigned

Comments: There have been reports of fetal and congenital abnormalities following in utero exposure.

Animal reproduction studies have not been conducted. There have been very rare reports of fetal and congenital abnormalities following in utero exposure to this drug. This drug should not be used in early pregnancy unless in the judgment of the physician the potential benefits outweigh the potential harm. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Methocarbamol Breastfeeding Warnings

Benefit should outweigh risk

Excreted into human milk: Unknown
Excreted into animal milk: Yes

Comments: This drug and/or its metabolites are excreted in the milk of dogs; there is not information on its excretion in human milk.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer